Wikidata

(Q45231654)

English

Rofecoxib attenuates both primary and secondary inflammatory hyperalgesia: a randomized, double blinded, placebo controlled crossover trial in the UV-B pain model

scientific article published in February 2005

In more languages

Statements

title
Rofecoxib attenuates both primary and secondary inflammatory hyperalgesia: a randomized, double blinded, placebo controlled crossover trial in the UV-B pain model (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15661439
retrieved
11 December 2017
author name string
Thomas Sycha
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15661439
retrieved
11 December 2017
Sebastian Anzenhofer
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15661439
retrieved
11 December 2017
Stephan Lehr
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15661439
retrieved
11 December 2017
Boris Chizh
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15661439
retrieved
11 December 2017
Hans-Georg Eichler
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15661439
retrieved
11 December 2017
Burkhard Gustorff
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
15661439
retrieved
11 December 2017
publication date
1 February 2005
1 reference
stated in
Europe PubMed Central
PubMed ID
15661439
retrieved
11 December 2017
page(s)
316-322
1 reference
stated in
Europe PubMed Central
PubMed ID
15661439
retrieved
11 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q45231654&oldid=2070744286"